Hongkongers Start Receiving BioNTech Jabs
"); jQuery("#212 h3").html("

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1579748_1_20210310182932.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1579748-20210310.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1579748-20210310.htm', 'DCS.dcsqry', '' ); } } }); }); });
2021-03-10 HKT 13:14
Hong Kong on Wednesday began inoculating people against coronavirus with Germany's BioNTech vaccine, with some of those first in the queue saying they believe it will be safer and more effective than the Sinovac jab also available.
Seven centres – in Sai Ying Pun, Sai Wan Ho, Kowloon Tong, Kwun Tong, Lai Chi Kok, Sheung Shui and Yuen Long are now providing the BioNTech jabs, for priority groups at first.
Many of those who had booked appointments at the Kowloon Tong centre on Wednesday were foreign residents. People RTHK spoke to said they were confident about receiving the vaccine.
“I’m not afraid at all. Not at all. Because they have a full medical report published, and millions and millions of people abroad have already taken the jabs. I know there are no serious side effects,” said an 80-year-old man.
A pharmacist surnamed Lam agreed that any side effects should be mild.
"From overseas experience, this vaccine is also used in high risk groups, for the elderly and also people with chronic diseases. I have confidence in this vaccine," she said.
A 76-year-old man surnamed Azim said he was not concerned about having an adverse reaction to the jab.
“I’m in good health, so no problem for me,” he laughed.
“We were told that Pfizer/BioNTech is the best. Pfizer has more efficacy,” he added.
A man surnamed Lam, meanwhile, said he didn't want to take the Sinovac jab after seeing news reports about deaths and hospitalisations among people who had received it.
“I’m not confident about it. You can see on the news, one case after another. If I’m unlucky, I might be one of them,” he said.
Authorities and experts have said they don't believe the recent deaths were linked to the Sinovac jabs, and some of those taking the BioNTech vaccine on Wednesday said they would have preferred to get the China-made vaccine, but couldn't get an appointment slot.
Most of the people RTHK spoke to said they felt fine after having the BioNTech jab. They will need to take a second dose after three weeks.
SBI Holdings To Acquire Bitbank In US$289M Crypto Expansion
SBI Holdings has agreed to acquire Japanese crypto exchange Bitbank in a deal valued at approximately US$289 million, w... Read more
4 Ways Hong Kong Banks Fight Financial Crime Using AI, According To HKMA
The Hong Kong Monetary Authority (HKMA) wants banks to use AI in financial crime as a way to counter cyberattacks and s... Read more
Ripple Launches RLUSD Stablecoin In Japan Through SBI Group
Ripple has launched its US dollar-denominated stablecoin, Ripple USD, in the Japanese market. The expansion follows reg... Read more
SBI And Startale Launch Trust Bank-Backed Yen Stablecoin JPYSC In Japan
SBI Group has introduced its trust based stablecoin JPYSC in partnership with Singapore-based fintech company Startale ... Read more
Visa Study: Digital Wallets Lead Greater Bay Area Payment Preferences
Visa has released its latest Consumer Payment Attitudes Study, highlighting how payment seamlessness is linked to a shi... Read more
European And South Korean Banks Form Project Pangea For FX Settlement
Chainlink, South Korean infrastructure provider FairSquareLab, the Unified Korea Alliance (UniKA), and European stablec... Read more